Mast cell exosomes promote lung adenocarcinoma cell proliferation-role of KIT-stem cell factor signaling

Cell Communication and Signaling

Volumn 12, Issue 1, 2014, Pages

  Xiao, Hui ^a,b   Lässer, Cecilia ^b   Shelke, Ganesh Vilas ^b   Wang, Juan ^a   Rådinger, Madeleine ^b   Lunavat, Taral Rameshchand ^b   Malmhä, Carina ^b   Lin, Li Hui ^a   Li, Jia ^a   Li, Li ^a   Lötva, Jan ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Exosomes; Extracellular vesicles; KIT; Lung cancer; Mast cell; Transfer

Indexed keywords

BROXURIDINE; CYCLIN D1; KIT STEM CELL FACTOR; MESSENGER RNA; STEM CELL FACTOR; UNCLASSIFIED DRUG; CCND1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; STEM CELL FACTOR RECEPTOR;

ARTICLE; CELL ISOLATION; CELL LABELING; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; EPITHELIUM CELL; EXOSOME; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; 3T3 CELL LINE; ADENOCARCINOMA; ANIMAL; CELL LINE; GENETICS; LUNG TUMOR; METABOLISM; MOUSE; PATHOLOGY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; EXOSOMES; HUMANS; LUNG NEOPLASMS; MAST CELLS; MICE; NIH 3T3 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84988596427     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0064-8     Document Type: Article

References (44)

1. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996, 183:1161-1172.
2. Nolte-'t Hoen EN, Buschow SI, Anderton SM, Stoorvogel W, Wauben MH: Activated T cells recruit exosomes secreted by dendritic cells via LFA-1.Blood 2009, 113:1977-1981.
3. Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S: Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes.Nat Med 1998, 4:594-600.
4. Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C: Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.Mol Biol Cell 1997, 8:2631-2645.
5. Fais S: NK cell-released exosomes: Natural nanobullets against tumors.Oncoimmunology 2013, 2:e22337.
6. Buning J, von Smolinski D, Tafazzoli K, Zimmer KP, Strobel S, Apostolaki M, Kollias G, Heath JK, Ludwig D, Gebert A: Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes. Immunology 2008, 125:510-521.
7. Hood JL, San RS, Wickline SA: Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res 2011, 71:3792-3801.
8. Friel AM, Corcoran C, Crown J, O'Driscoll L: Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.Breast Cancer Res Treat 2010, 123:613-625.
9. Bellingham SA, Coleman BM, Hill AF: Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucleic Acids Res 2012, 40:10937-10949.
10. Chaput N, Thery C: Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 2011, 33:419-440.
11. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL: Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012, 151:1542-1556.
12. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO: Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
13. Aliotta JM, Pereira M, Li M, Amaral A, Sorokina A, Dooner MS, Sears EH, Brilliant K, Ramratnam B, Hixson DC, Quesenberry PJ: Stable cell fate changes in marrow cells induced by lung-derived microvesicles.J Extracellular Vesicles 2012, 1.
14. Lässer C, Alikhani VS, Ekström K, Eldh M, Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S, Lötvall J, Valadi H: Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 2011, 9:9.
15. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C: Exosomal-like vesicles are present in human blood plasma. Int Immunol 2005, 17:879-887.
16. Admyre C, Johansson SM, Qazi KR, Filen JJ, Lahesmaa R, Norman M, Neve EP, Scheynius A, Gabrielsson S: Exosomes with immune modulatory features are present in human breast milk. J Immunol 2007, 179:1969-1978.
17. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS, Chalmers RT, Webb DJ, Dear JW: Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 2012, 10:5.
18. Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 2004, 101:13368-13373.
19. Kahlert C, Kalluri R: Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) 2013, 91:431-437.
20. Park JE, Tan HS, Datta A, Lai RC, Zhang H, Meng W, Lim SK, Sze SK: Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics 2010, 9:1085-1099.
21. Jensen BM, Akin C, Gilfillan AM: Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders. Br J Pharmacol 2008, 154:1572-1582.
22. Rådinger M, Kuehn HS, Kim MS, Metcalfe DD, Gilfillan AM: Glycogen synthase kinase 3beta activation is a prerequisite signal for cytokine production and chemotaxis in human mast cells. J Immunol 2010, 184:564-572.
23. Xiao H, Wang J, Liu Y, Li L: Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncology Letter 2014, 8:582-588.
24. Regan JL, Kendrick H, Magnay FA, Vafaizadeh V, Groner B, Smalley MJ: c-Kit is required for growth and survival of the cells of origin of Brca1-mutationassociated breast cancer. Oncogene 2012, 31:869-883.
25. Macher-Goeppinger S, Penzel R, Roth W, Dienemann H, Thomas M, Schnabel PA, Schirmacher P, Blaker H: Expression and mutation analysis of EGFR, c-KIT, and beta-catenin in pulmonary blastoma. J Clin Pathol 2011, 64:349-353.
26. Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK: Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci U S A 2014, 111:711-716.
27. Jacobs B, Ullrich E: The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions? Curr Med Chem 2012, 19:1771-1779.
28. Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J, Stattin P, Egevad L, Granfors T, Wikstrom P, Bergh A: Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol 2010, 177:1031-1041.
29. Ham M, Moon A: Inflammatory and microenvironmental factors involved in breast cancer progression. Arch Pharm Res 2013, 36:1419-1431.
30. Evani SJ, Prabhu RG, Gnanaruban V, Finol EA, Ramasubramanian AK: Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow. FASEB J 2013, 27:3017-3029.
31. Stoyanov E, Uddin M, Mankuta D, Dubinett SM, Levi-Schaffer F: Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer 2012, 75:38-44.
32. Lässer C, Eldh M, Lötvall J: Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012, 9:59.
33. Lässer C, O'Neil SE, Ekerljung L, Ekström K, Sjöstrand M, Lötvall J: RNA-containing exosomes in human nasal secretions. Am J Rhinol Allergy 2011, 25:89-93.
34. Ekström K, Valadi H, Sjöstrand M, Malmhall C, Bossios A, Eldh M, Lötvall J: Characterization of mRNA and microRNA in human mast cell-derived exosomes and their transfer to other mast cells and blood CD34 progenitor cells. J Extracellular Vesicles 2012, 1.
35. Crescitelli R, Lasser C, Szabo TG, Kittel A, Eldh M, Dianzani I, Buzas EI, Lotvall J: Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracellular Vesicles 2013, 2.
36. Herpel E, Jensen K, Muley T, Warth A, Schnabel PA, Meister M, Herth FJ, Dienemann H, Thomas M, Gottschling S: The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res 2011, 31:4491-4500.
37. Itkin T, Ludin A, Gradus B, Gur-Cohen S, Kalinkovich A, Schajnovitz A, Ovadya Y, Kollet O, Canaani J, Shezen E, Coffin DJ, Enikolopov GN, Berg T, Piacibello W, Hornstein E, Lapidot T: FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. Blood 2012, 120:1843-1855.
38. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA: Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003, 21:4342-4349.
39. Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R: Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer. Int J Cancer 2004, 111:259-263.
40. Attoub S, Rivat C, Rodrigues S, Van Bocxlaer S, Bedin M, Bruyneel E, Louvet C, Kornprobst M, Andre T, Mareel M, Mester J, Gespach C: The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy. Cancer Res 2002, 62:4879-4883.
41. El-Serafi MM, Bahnassy AA, Ali NM, Eid SM, Kamel MM, Abdel-Hamid NA, Zekri AR: The prognostic value of c-Kit, K-ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer. Cancer 2010, 116:4954-4964.
42. Yasuda A, Sawai H, Takahashi H, Ochi N, Matsuo Y, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T: The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells.Mol Cancer 2006, 5:46.
43. Engelman JA: Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009, 9:550-562.
44. Koyasu S: The role of PI3K in immune cells. Nat Immunol 2003, 4:313-319.